<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN" "http://jats.nlm.nih.gov/publishing/1.0/JATS-journalpublishing1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="article-commentary" dtd-version="1.0" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="issn">1043-3155</journal-id>
<journal-id journal-id-type="nlm-ta">Pediatr Neurol Briefs</journal-id>
<journal-id journal-id-type="pmc">pedneurbriefs</journal-id>
<journal-id journal-id-type="iso-abbrev">Pediatr Neurol Briefs</journal-id>
<journal-title-group>
<journal-title>Pediatric Neurology Briefs</journal-title>
<abbrev-journal-title>Pediatr Neurol Briefs</abbrev-journal-title>
</journal-title-group>
<issn pub-type="epub">2166-6482</issn>
<issn pub-type="ppub">1043-3155</issn>
<issn-l>2166-3155</issn-l>
<publisher>
<publisher-name>Pediatric Neurology Briefs Publishers</publisher-name>
<publisher-loc>Chicago, IL, USA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">PNB-24-47-a</article-id>
<article-id pub-id-type="doi">10.15844/pedneurbriefs-24-6-8</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Vascular Disorders</subject>
</subj-group>
<subj-group subj-group-type="Discipline-v2">
<subject>Neurology</subject>
<subject>Pediatrics</subject>
<subject>Nervous System Diseases</subject>
<subject>Child Development</subject>
<subject>Brain Diseases</subject>
<subject>Neurosurgery</subject>
<subject>Child</subject>
<subject>Infant</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Anticoagulants in Pediatric Sinovenous Thrombosis</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-0173-7931</contrib-id>
<name>
<surname>Millichap</surname>
<given-names>J. Gordon</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="AF0001">1</xref>
<xref ref-type="aff" rid="AF0002">2</xref>
<xref ref-type="corresp" rid="cor1">&#x002A;</xref>
</contrib>
</contrib-group>
<aff id="AF0001">
<label>1</label>Division of Neurology, Children&#x0027;s Memorial Hospital, Chicago, IL</aff>
<aff id="AF0002">
<label>2</label>Departments of Pediatrics and Neurology, Northwestern University Feinberg School of Medicine, Chicago, IL</aff>
<author-notes>
<corresp id="cor1"><label>&#x002A;</label>Correspondence: Dr. J. Gordon Millichap, E-mail: <email xlink:href="jgmillichap@northwestern.edu">jgmillichap@northwestern.edu</email>
</corresp>
</author-notes>
<pub-date date-type="pub" publication-format="print">
<month>06</month>
<year>2010</year>
</pub-date>
<pub-date date-type="pub" publication-format="electronic">
<day>01</day>
<month>01</month>
<year>2016</year>
</pub-date>
<volume>24</volume>
<issue>6</issue>
<fpage>47</fpage>
<lpage>47</lpage>
<permissions>
<copyright-statement>Copyright: &#x00A9; 2010 The Author(s)</copyright-statement>
<copyright-year>2010</copyright-year>
<license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This work is licensed under the <uri xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution 4.0 International License</uri>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
</license>
</permissions>
<related-article id="R1" related-article-type="commentary-article" ext-link-type="doi" xlink:href="10.1002/ana.21936" vol="67" page="590">
<article-title>Anticoagulants in pediatric sinovenous thrombosis: a safety and outcome study</article-title>
</related-article>
<abstract abstract-type="web-summary" specific-use="electronic-only">
<p>Safety and outcome of anticoagulant therapy in neonates and children with cerebral sinovenous thrombosis (CSVT) were determined in a study at the Hospital for Sick Children and Toronto Western Hospital, Ontario, Canada.</p>
</abstract>
<kwd-group>
<kwd>Cerebral Sinovenous Thrombosis</kwd>
<kwd>Prothrombotic Abnormalities</kwd>
<kwd>Anticoagulants</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<p>Safety and outcome of anticoagulant therapy in neonates and children with cerebral sinovenous thrombosis (CSVT) were determined in a study at the Hospital for Sick Children and Toronto Western Hospital, Ontario, Canada. Neonates presented with seizures and encephalopathy, children had headache and raised intracranial pressure. Prothrombotic abnormalities occurred in 76%. Among 162 pediatric patients, 85 received anticogulants (standard/low molecular weight heparin, warfarin), including 29/83 (35%) neonates and 56/79 (71%) children. Mean interval from diagnosis to anticoagulant initiation was 4 days. Major hemorrhage occurred in 6% (6/99) of treated patients; they were all nonfatal and clinical outcome was favorable in 50%. Follow-up imaging showed thrombus propagation in 11/57 neonates (10/35 [28%] without and 1/22 [4%] with anticoagulant therapy (p=0.037)) and in 10/63 children (7/19 [37%] without and 3/44 [7%] with anticoagulant [p=0.006]). Propagation was associated with new venous infarcts in 10% neonates and 40% children and worse clinical outcome in children (p=0.053). Recanalization occurred earlier and more completely in neonates (p=0.002). Clinical outcome was unfavorable in 47%. [<xref ref-type="bibr" rid="CIT0001">1</xref>]</p>
<p>COMMENT. In this large single-center cohort study of anticoagulant safety in pediatric CSVT, treatment-related hemorrhage was infrequent whereas in untreated patients, thrombus propagation was frequent, occurring in one-third patients. The authors conclude that anticoagulants deserve strong consideration in pediatric CSVT.</p>
</body>
<back>
<ref-list>
<ref id="CIT0001">
<label>1</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moharir</surname>
<given-names>MD</given-names>
</name>
<name>
<surname>Shroff</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Stephens</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Pontigon</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Chan</surname>
<given-names>A</given-names>
</name>
<name>
<surname>MacGregor</surname>
<given-names>D</given-names>
</name>
<etal/>
</person-group>
<article-title>Anticoagulants in pediatric sinovenous thrombosis: a safety and outcome study</article-title>
<source>Ann Neurol</source>
<year>2010</year>
<month>May</month>
<volume>67</volume>
<issue>5</issue>
<fpage>590</fpage>
<lpage>599</lpage>
<pub-id pub-id-type="doi">10.1002/ana.21936</pub-id>
<pub-id pub-id-type="pmid">20437556</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
</article>
